The strategy for the management of type 2 diabetes was updated in 2018 in response to the abundance of new cardiovascular outcome data from the CVOTs published since 2015, which showed safety, tolerability, and cardiovascular and renoprotection with 2 classes of agents, sodium glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide receptor agonists (GLP1RA) in patients with established CVD (11)
In healthy men, intraduodenal infusion of glucose induces a rapid 200% increase in GLP-1 that returns to baseline by 30 min (Herrmann et al., 1995)
Algunos pacientes tambin suspenden prematuramente el tratamiento debido a efectos secundarios gastrointestinales como nuseas, vmitos o diarrea, que suelen ser transitorios y disminuyen con el tiempo
Frontiers in Endocrinology, 14, 1209975
We may also use technologies to determine if you are shopping in one of our stores by relying on signals transmitted by your mobile devices